These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 30395988)

  • 41. Outcomes and Risk Factors in Prosthetic Joint Infections by multidrug-resistant Gram-negative Bacteria: A Retrospective Cohort Study.
    da Silva RB; Salles MJ
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33807001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.
    Petrosillo N; Giannella M; Antonelli M; Antonini M; Barsic B; Belancic L; Inkaya A C; De Pascale G; Grilli E; Tumbarello M; Akova M
    Antimicrob Agents Chemother; 2014; 58(2):851-8. PubMed ID: 24277037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidrug-resistant Gram-negative bacteria: how to treat and for how long.
    Giamarellou H
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Use of Polymyxin B.
    Rigatto MH; Falci DR; Zavascki AP
    Adv Exp Med Biol; 2019; 1145():197-218. PubMed ID: 31364080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
    Fernandes M; Vira D; Medikonda R; Kumar N
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli.
    Falcone M; Tiseo G; Dentali F; La Regina M; Foglia E; Gambacorta M; Garagiola E; Bonardi G; Clerici P; Colombo F; Farcomeni A; Concia E; Corrao S; Campanini M; Mazzone A
    Eur J Intern Med; 2018 Jul; 53():21-28. PubMed ID: 29426676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
    Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience.
    Meschiari M; Faltoni M; Kaleci S; Tassoni G; Orlando G; Franceschini E; Burastero G; Bedini A; Serio L; Biagioni E; Melegari G; Venturelli C; Sarti M; Bertellini E; Girardis M; Mussini C
    Int J Antimicrob Agents; 2024 May; 63(5):107134. PubMed ID: 38453094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
    Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
    Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit.
    Giuffrè M; Geraci DM; Bonura C; Saporito L; Graziano G; Insinga V; Aleo A; Vecchio D; Mammina C
    Medicine (Baltimore); 2016 Mar; 95(10):e3016. PubMed ID: 26962817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.
    Tseng WP; Chen YC; Yang BJ; Chen SY; Lin JJ; Huang YH; Fu CM; Chang SC; Chen SY
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1216-1225. PubMed ID: 28870265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colistin sulfate for decontamination of preservation fluid in kidney transplantation to decrease the incidence of donor-derived infections caused by multidrug-resistant Gram-negative bacteria.
    Sui M; Zheng N; Xu D; Li Y; Li Y; Pu S; Ji M; Yang S; Chen Y; Huang J; Zhu Y; Lu H; Zeng L
    Transpl Infect Dis; 2022 Jun; 24(3):e13820. PubMed ID: 35279926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.
    Giannitsioti E; Salles MJ; Mavrogenis A; Rodriguez-Pardo D; Los-Arcos I; Ribera A; Ariza J; Del Toro MD; Nguyen S; Senneville E; Bonnet E; Chan M; Pasticci MB; Petersdorf S; Benito N; O' Connell N; Blanco García A; Skaliczki G; Tattevin P; Kocak Tufan Z; Pantazis N; Megaloikonomos PD; Papagelopoulos P; Soriano A; Papadopoulos A; The Esgiai Collaborators Study Group
    J Bone Jt Infect; 2022; 7(6):279-288. PubMed ID: 36644590
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention.
    Tornero E; Morata L; Martínez-Pastor JC; Angulo S; Combalia A; Bori G; García-Ramiro S; Bosch J; Mensa J; Soriano A
    J Antimicrob Chemother; 2016 May; 71(5):1395-401. PubMed ID: 26929270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.
    Parchem NL; Bauer KA; Cook CH; Mangino JE; Jones CD; Porter K; Murphy CV
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1433-9. PubMed ID: 27230510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    Hawkey PM; Warren RE; Livermore DM; McNulty CAM; Enoch DA; Otter JA; Wilson APR
    J Antimicrob Chemother; 2018 Mar; 73(suppl_3):iii2-iii78. PubMed ID: 29514274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience.
    Grammatopoulos G; Kendrick B; McNally M; Athanasou NA; Atkins B; McLardy-Smith P; Taylor A; Gundle R
    J Arthroplasty; 2017 Jul; 32(7):2248-2255. PubMed ID: 28385345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.